Search
for
Sort by
Research 241–270 of 838
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Ritlecitinib: First Approval
- Wnt signaling: the good and the bad
- Metabolic dysfunction in female mice with disruption of 5α-reductase 1
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Hepatoprotective and anti-hyperplastic effects of silver nanoparticles biosynthesised using aqueous extracts of <i>M. scaber</i> : Insights from acetaminophen and testosterone experimental models
- The human keratins: biology and pathology
- Prospect of Stem Cell Conditioned Medium in Regenerative Medicine
- Leucine-Rich Repeat-Containing G-Protein-Coupled Receptors as Markers of Adult Stem Cells
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- The diagnosis and treatment of iron deficiency and its potential relationship to hair loss
- Anthracycline analogs The past, present, and future
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- Targeting the Wnt pathways for therapies
- Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies
- Hyaluronidase Modulates Inflammatory Response and Accelerates the Cutaneous Wound Healing
- Physiologic functions of PP2A: Lessons from genetically modified mice
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- YAP and TAZ are essential for basal and squamous cell carcinoma initiation
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Androgen receptors and their biology
- Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for <i>In Vivo</i> CRISPR/Cas-Based Genome Editing
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Edible seeds from Cucurbitaceae family as potential functional foods: Immense promises, few concerns
- Overactivated sonic hedgehog signaling aggravates intrauterine adhesion via inhibiting autophagy in endometrial stromal cells
- The therapeutic use of androgens in women
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Alopecia in patients treated with molecularly targeted anticancer therapies